Sphere Fluidics is an established, Life Sciences SME, focussing on single-cell analysis platforms and tools, spun out of Cambridge University in 2010. The company has successfully commercialised microfluidic hardware, consumables (biochips, reagents and chemicals) and software for the pharmaceutical industry, biotechs and academia.

Sphere Fluidics has modern labs, based in Granta Park, Cambridge, UK, for the development of new technology and an R&D team containing expert scientists and engineers. Sphere Fluidics also has a strong commercial team and has established 13 international distributor partnerships to enable its products to be sold across the world and has raised circa €50 million in equity and loans to date and has over 350 customers worldwide.